Currently out of the existing stock ratings of Priya Sachdeva, 9 are a BUY (60%), 6 are a HOLD (40%).
Analyst Priya Sachdeva, currently employed at UBS, has had 63.89% of price targets met with an average potential upside of 23.72%, reached in 193 days on average.
Priya Sachdeva has documented 29 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 03-Sep-2026.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for NPCE (NEUROPACE) on 1/21/2025. The price target of $17 was fulfilled within 114 days with a profit of $3.94 (30.17%), with a performance score of 2.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$12
$4.05 (50.94%)
$20
6 days ago
(16-Nov-2026)
Buy Since 23-Jul-2026
$12
$4.05 (50.94%)
$22
6 days ago
(16-Nov-2026)
Buy Since 27-May-2025
$7
$-0.95 (-11.95%)
$20
9 days ago
(13-Nov-2026)
1/4 (25%)
$-0.56 (-7.41%)
182
Buy Since 18-Sep-2026
$14
$6.05 (76.10%)
$18
9 days ago
(13-Nov-2026)
0/2 (0%)
$6.44 (85.19%)
Buy Since 10-Dec-2025
$9
$1.05 (13.21%)
$20
9 days ago
(13-Nov-2026)
0/2 (0%)
$1.44 (19.05%)
Which stock is Priya Sachdeva most bullish on?
What Year was the first public recommendation made by Priya Sachdeva?